Auswahl der wissenschaftlichen Literatur zum Thema „Syntenin/syndecan interaction“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Inhaltsverzeichnis
Machen Sie sich mit den Listen der aktuellen Artikel, Bücher, Dissertationen, Berichten und anderer wissenschaftlichen Quellen zum Thema "Syntenin/syndecan interaction" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Zeitschriftenartikel zum Thema "Syntenin/syndecan interaction"
Zimmermann, Pascale, Zhe Zhang, Gisèle Degeest, Eva Mortier, Iris Leenaerts, Christien Coomans, Joachim Schulz, Francisca N’Kuli, Pierre J. Courtoy und Guido David. „Syndecan Recyling Is Controlled by Syntenin-PIP2 Interaction and Arf6“. Developmental Cell 9, Nr. 3 (September 2005): 377–88. http://dx.doi.org/10.1016/j.devcel.2005.07.011.
Der volle Inhalt der QuelleZimmermann, Pascale, Zhe Zhang, Gisèle Degeest, Eva Mortier, Iris Leenaerts, Christien Coomans, Joachim Schulz, Francisca N’Kuli, Pierre J. Courtoy und Guido David. „Syndecan Recycling Is Controlled by Syntenin-PIP2 Interaction and Arf6“. Developmental Cell 9, Nr. 5 (November 2005): 721. http://dx.doi.org/10.1016/j.devcel.2005.10.011.
Der volle Inhalt der QuelleBASS, Mark D., und Martin J. HUMPHRIES. „Cytoplasmic interactions of syndecan-4 orchestrate adhesion receptor and growth factor receptor signalling“. Biochemical Journal 368, Nr. 1 (15.11.2002): 1–15. http://dx.doi.org/10.1042/bj20021228.
Der volle Inhalt der QuelleLee, Hawon, Yeonhee Kim, Youngsil Choi, Sojoong Choi, Eunkyung Hong und Eok-Soo Oh. „Syndecan-2 cytoplasmic domain regulates colon cancer cell migration via interaction with syntenin-1“. Biochemical and Biophysical Research Communications 409, Nr. 1 (Mai 2011): 148–53. http://dx.doi.org/10.1016/j.bbrc.2011.04.135.
Der volle Inhalt der QuelleImjeti, Naga Sailaja, Kerstin Menck, Antonio Luis Egea-Jimenez, Celine Lecointre, Frederique Lembo, Habib Bouguenina, Ali Badache et al. „Syntenin mediates SRC function in exosomal cell-to-cell communication“. Proceedings of the National Academy of Sciences 114, Nr. 47 (06.11.2017): 12495–500. http://dx.doi.org/10.1073/pnas.1713433114.
Der volle Inhalt der QuellePradhan, Anjan K., Jinkal Modi, Santanu Maji, Amit Kumar, Praveen Bhoopathi, Padmanabhan Mannangatti, Chunqing Guo et al. „Abstract 3394: Simultaneous targeting of the PDZ1 and PDZ2 domains of MDA-9 inhibits melanoma metastasis“. Cancer Research 83, Nr. 7_Supplement (04.04.2023): 3394. http://dx.doi.org/10.1158/1538-7445.am2023-3394.
Der volle Inhalt der QuelleZhao, Tian, Xiaolan Yang, Guangfei Duan, Jialin Chen, Kefeng He, Yong‐Xiang Chen und Shi‐Zhong Luo. „Phosphorylation‐regulated phase separation of syndecan‐4 and syntenin promotes the biogenesis of exosomes“. Cell Proliferation, 11.04.2024. http://dx.doi.org/10.1111/cpr.13645.
Der volle Inhalt der QuellePradhan, Anjan K., Jinkal Modi, Santanu Maji, Amit Kumar, Praveen Bhoopathi, Padmanabhan Mannangatti, Chunqing Guo et al. „Dual Targeting of the PDZ1 and PDZ2 Domains of MDA-9/Syntenin Inhibits Melanoma Metastasis“. Molecular Cancer Therapeutics, 18.09.2023, OF1—OF13. http://dx.doi.org/10.1158/1535-7163.mct-22-0653.
Der volle Inhalt der QuelleHoffer, Laurent, Manon Garcia, Raphael Leblanc, Mikael Feracci, Stéphane Betzi, Khaoula Ben Yaala, Avais M. Daulat et al. „Discovery of a PDZ Domain Inhibitor Targeting the Syndecan/Syntenin Protein–Protein Interaction: A Semi-Automated “Hit Identification-to-Optimization” Approach“. Journal of Medicinal Chemistry, 20.03.2023. http://dx.doi.org/10.1021/acs.jmedchem.2c01569.
Der volle Inhalt der QuelleLiu, Jing, Weiwei Bai, Tianxing Zhou, Yongjie Xie, Bo Yang, Jingyan Sun, Yifei Wang et al. „SDCBP promotes pancreatic cancer progression by preventing YAP1 from β-TrCP-mediated proteasomal degradation“. Gut, 24.02.2023, gutjnl—2022–327492. http://dx.doi.org/10.1136/gutjnl-2022-327492.
Der volle Inhalt der QuelleDissertationen zum Thema "Syntenin/syndecan interaction"
Garcia, Manon. „Développement de nouveaux agents anticancéreux inhibiteurs de la syntenin“. Electronic Thesis or Diss., Aix-Marseille, 2021. http://theses.univ-amu.fr.lama.univ-amu.fr/210312_GARCIA_59el396udxeux306vl471dzd_TH.pdf.
Der volle Inhalt der QuelleThe thesis describes the identification and optimization of selective inhibitors targeting the syntenin/syndecan complex, using a “Fragment-based drug design” (FBDD) strategy, which could pave the way for new anticancer therapies. The syntenin/syndecan interaction plays a major role in the recycling of endosomes to the plasma membrane, as well as in the biogenesis and release of exosomes derived from tumor cells. Therefore, we performed an FBDD program targeting selectively the syntenin/syndecan interaction. To do this, two different fragment library screenings were performed, one experimental the other virtual, and two fragments hits were identified that specifically inhibit the interaction of the syntenin/syndecan complex. The resolution of 3D crystallographic structures of the complexes between these two fragments and syntenin allowed their optimization by a structure-based drug design approach based on information about their binding site and the mode. SAR studies and fragment growing optimization steps, based on molecular docking studies, were carried out. My work consisted in synthesizing chemical libraries of targeted analogues resulting from molecular docking and demonstrating strong interactions with syntenin. Among all the synthesized analogues, we identified the most promising inhibitors which exhibit sub-micromolar IC50 and which affect the release pathway of exosomes derived from tumor cells, dependent on syntenin/syndecan activity